Thus, further understanding the role of TRAP1 chaperone activity in oncogenic transition from healthy to tumour state under influence of different internal (genetic and metabolic) and external (toxins and environmental) factors would open a new line of possibilities to invent effective anti-CRC therapies and define innovative anti-neoplastic strategies. Here, TRAP1 is linked to neoplasm.